Trial Profile
The Impact of Ticagrelor on Coronary Atherosclerotic Lipid Pool and Inflammation Assessed by Near-Infrared Spectroscopy
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 09 Apr 2021
Price :
$35
*
At a glance
- Drugs Ticagrelor (Primary)
- Indications Acute coronary syndromes; Coronary artery disease
- Focus Pharmacodynamics
- 30 Jun 2016 Status changed from active, no longer recruiting to completed.
- 08 Nov 2014 New trial record